FRNRX
Price
$42.26
Change
-$0.04 (-0.09%)
Updated
Jul 9 closing price
Net Assets
484.54M
ICBMX
Price
$21.05
Change
+$0.11 (+0.53%)
Updated
Jul 9 closing price
Net Assets
131.56M
Interact to see
Advertisement

FRNRX vs ICBMX

FRNRX vs ICBMX Comparison Chart in %
View a ticker or compare two or three
VS
FRNRX vs. ICBMX commentary
Jul 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRNRX is a Buy and ICBMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FRNRX has more cash in the bank: 485M vs. ICBMX (132M). FRNRX pays higher dividends than ICBMX: FRNRX (1.47) vs ICBMX (1.29). FRNRX was incepted earlier than ICBMX: FRNRX (31 years) vs ICBMX (29 years). ICBMX (1.31) is less costly to investors than FRNRX (1.01). ICBMX is a more actively managed with annual turnover of: 154.00 vs. FRNRX (19.72). FRNRX (1000) and ICBMX (1000) have matching initial minimum investment requirements. FRNRX annual gain was more profitable for investors over the last year : 36.21 vs. ICBMX (19.94). FRNRX return over 5 years is better than : 112.97 vs. ICBMX (31.56).
FRNRXICBMXFRNRX / ICBMX
Total Expense Ratio1.001.3176%
Annual Report Gross Expense Ratio1.011.3177%
Fund Existence31 years29 years-
Gain YTD15.68616.98092%
Front Load6%N/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets485M132M367%
Annual Yield % from dividends1.471.29115%
Returns for 1 year36.2119.94182%
Returns for 3 years56.1124.26231%
Returns for 5 years112.9731.56358%
Returns for 10 years80.5183.1397%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VNT29.420.50
+1.73%
Vontier Corp
BMGL6.730.08
+1.20%
Basel Medical Group Ltd
ALC67.810.67
+1.00%
Alcon
MATW26.66-0.32
-1.19%
Matthews International Corp
BZUN2.84-0.04
-1.39%
Baozun